Myriad Genetics · 16 hours ago
Reimbursement Specialist Patient Accounts (Remote - Call Center Experience Preferred)
United States
Full-time
Remote
Entry Level
1+ years expMyriad Genetics is a leading personalized medicine company dedicated to transforming patient lives worldwide with pioneering molecular diagnostics. They are seeking a Patient Account Reimbursement Specialist to join their Billing & Collections team, responsible for resolving billing inquiries from patients and ensuring timely processing of accounts.
BiotechnologyMedical DevicePharmaceuticalPrecision Medicine
Responsibilities
Primary job function is taking inbound calls from patients to resolve billing related inquiries
Works aged patient accounts, researches and reconciles credit balance accounts and processes adjustments as needed
Interacts with patients, clinicians, insurers, Reimbursement Supervisor and Billing management to ensure timely processing of workload
Reviews patient’s insurance coverage for genetic testing
Document activities appropriately in process notes
Participates in the Quality Assurance plan
Complies with applicable CLIA and HIPAA regulations
Qualification
Required
High School Diploma or GED required
Good problem solving and decision-making skills
Excellent customer service and phone skills
Excellent time management, organizational, communication, multitasking and teamwork skills
Ability to successfully navigate between multiple systems throughout the course of the work-day. This includes but is not limited to billing software, written Standard Operating Procedures and payment portals
Preferred
1-year customer service/call center experience preferred
1-year of experience working in medical billing, health insurance or collections with demonstrated results preferred
Insurance billing experience is preferred
Bilingual English/Spanish preferred
Working knowledge of ICD-10, CPT and HCPCS coding (preferred but not required)
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Leadership Team
Sam Raha
CEO | President | Board member
Ben Wheeler
Chief Financial Officer
Recent News
Company data provided by crunchbase